|
Volumn 16, Issue 1, 2002, Pages 69-77
|
A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BALSALAZIDE;
SALAZOSULFAPYRIDINE;
ABDOMINAL PAIN;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG SAFETY;
EDEMA;
FEMALE;
HEADACHE;
HUMAN;
MALE;
MULTICENTER STUDY;
NAUSEA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RASH;
SIGMOIDOSCOPY;
TREATMENT OUTCOME;
ULCERATIVE COLITIS;
VERTIGO;
ADMINISTRATION, ORAL;
ADULT;
AGED;
AGED, 80 AND OVER;
AMINOSALICYLIC ACIDS;
ANTI-ULCER AGENTS;
COLITIS, ULCERATIVE;
DOUBLE-BLIND METHOD;
FEMALE;
GASTROINTESTINAL AGENTS;
HUMANS;
MALE;
MESALAMINE;
MIDDLE AGED;
PHENYLHYDRAZINES;
SEVERITY OF ILLNESS INDEX;
SIGMOIDOSCOPY;
SULFASALAZINE;
TREATMENT OUTCOME;
|
EID: 0036164249
PISSN: 02692813
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2036.2002.01151.x Document Type: Article |
Times cited : (62)
|
References (28)
|